Company profile
Vitestro
Vitestro develops autonomous blood-drawing systems for clinical environments. Its robot combines ultrasound-guided needle placement, computer vision and ro...
Facts
- Segment
- HEALTHCARE
- Country
- Netherlands
- Headquarters
- Utrecht
- Founded
- 2017
- Website
- https://vitestro.com
About Vitestro
Vitestro's Aletta automates a diagnostic blood draw from tourniquet placement through vein selection, needle insertion, tube changing and inversion, needle withdrawal and bandage application. Near-infrared imaging locates candidate vessels, ultrasound evaluates them and Doppler confirms that the selected target is a vein before the robot positions the needle with submillimetre precision.
A trained supervisor loads the collection tubes and can oversee as many as three devices, while patients receive step-by-step guidance and can pause or stop the procedure. Aletta uses a sterile needle for each draw and stores completed samples inside the unit for staff retrieval. The system is CE-marked for clinical use in the European Union and operates at Dutch hospital trial and early-adopter sites; it is not approved or sold in the United States.
Market context
DEPLOYMENT
Summary
Type: Medical robotics
Core: Blood-draw robot
Function: Phlebotomy
Audience: Healthcare providers
Research, Articles and recent verified events
- Vitestro raises $70M Series B to advance autonomous robotic phlebotomy and commercial readiness — 2026-03-10
- Vitestro achieves CE marking for autonomous blood drawing device — 2024-08-28
- Danish hospital pre-orders 3 blood drawing devices in first international deployment for Vitestro — 2024-05-21
- Vitestro secures $22 million (€20 million) for autonomous blood draw device — 2024-04-30
- Vitestro secures order from Result Laboratorium for two blood drawing devices — 2024-04-03